Pendal Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $11.2M | Buy |
218,255
+40,813
| +23% | +$2.09M | 0.1% | 117 |
|
|
2022
Q3 | $7.77M | Sell |
177,442
-19,618
| -10% | -$858K | 0.08% | 118 |
|
|
2022
Q2 | $10.3M | Sell |
197,060
-57,866
| -23% | -$3.03M | 0.1% | 112 |
|
|
2022
Q1 | $13.2M | Buy |
254,926
+25,083
| +11% | +$1.3M | 0.11% | 110 |
|
|
2021
Q4 | $13.6M | Sell |
229,843
-10,215
| -4% | -$603K | 0.11% | 110 |
|
|
2021
Q3 | $10.3M | Sell |
240,058
-93,946
| -28% | -$4.04M | 0.09% | 116 |
|
|
2021
Q2 | $13.1M | Buy |
334,004
+53,470
| +19% | +$2.09M | 0.12% | 95 |
|
|
2021
Q1 | $10.2M | Sell |
280,534
-1,797
| -0.6% | -$65.1K | 0.1% | 100 |
|
|
2020
Q4 | $10.4M | Sell |
282,331
-165,456
| -37% | -$6.09M | 0.11% | 87 |
|
|
2020
Q3 | $15.6M | Sell |
447,787
-167,350
| -27% | -$5.83M | 0.19% | 61 |
|
|
2020
Q2 | $19.1M | Buy |
615,137
+69,605
| +13% | +$2.16M | 0.26% | 53 |
|
|
2020
Q1 | $16.9M | Buy |
545,532
+26,497
| +5% | +$821K | 0.29% | 49 |
|
|
2019
Q4 | $19.3M | Sell |
519,035
-16,057
| -3% | -$597K | 0.25% | 52 |
|
|
2019
Q3 | $18.2M | Sell |
535,092
-63,084
| -11% | -$2.15M | 0.24% | 54 |
|
|
2019
Q2 | $24.5M | Sell |
598,176
-247,361
| -29% | -$10.1M | 0.34% | 50 |
|
|
2019
Q1 | $34.1M | Buy |
845,537
+113,854
| +16% | +$4.59M | 0.47% | 47 |
|
|
2018
Q4 | $30.2M | Buy |
731,683
+123,642
| +20% | +$5.11M | 0.48% | 51 |
|
|
2018
Q3 | $25.4M | Buy |
608,041
+257,910
| +74% | +$10.8M | 0.35% | 53 |
|
|
2018
Q2 | $12.1M | Buy |
350,131
+74,418
| +27% | +$2.56M | 0.16% | 98 |
|
|
2018
Q1 | $9.28M | Sell |
275,713
-434,067
| -61% | -$14.6M | 0.12% | 121 |
|
|
2017
Q4 | $24.4M | Sell |
709,780
-22,943
| -3% | -$788K | 0.32% | 53 |
|
|
2017
Q3 | $24.9M | Buy |
732,723
+227,286
| +45% | +$7.71M | 0.32% | 58 |
|
|
2017
Q2 | $16.1M | Buy |
+505,437
| New | +$16.1M | 0.23% | 80 |
|